SIGACHI
NSESigachi Industries Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹20.64
0.01 (0.05%)
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹789 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹16.65+24.0%
52W High₹59.59-65.4%
Current Price
₹20.64
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹19.61
Upper Circuit₹21.67
Reference Price
₹20.64
Investment Checklist
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹21.73
Inverse Head and Shoulders on 1W — target ₹29.64
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Volume divergence: Bullish (price down, volume up)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
44%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
21.02
EMA50
21.08
EMA200
28.15
Price Action
DOWNTREND
BEARISH
Higher Highs2
Higher Lows3
Lower Highs7
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹22.64
₹23.80
₹26.65
₹30.52
₹32.66
Support (Below)
₹20.08
₹19.50
₹18.95
₹18.30
₹17.96
Volume Analysis
TrendINCREASING
Change+12.90%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹20.43
3% Risk₹20.02
5% Risk₹19.61
7% Risk (Custom)
₹19.20Technical Levels
1x ATR (Volatility)₹19.81
2x ATR (Swing)₹18.98
3x ATR (Trend)₹18.15
Immediate Support₹20.08
Financials
Financial Analysis
| Metric | Sep '24 | Dec '24 | Mar '25 | Jun '25 |
|---|---|---|---|---|
| Revenue | ₹124.9 Cr | ₹139.4 Cr | ₹128.2 Cr | ₹128.2 Cr |
| Net Profit | ₹21.8 Cr | ₹21.4 Cr | ₹13.3 Cr | ₹-100.4 Cr |
| EPS | ₹0.66 | ₹0.65 | — | ₹-2.63 |
| Operating Profit | ₹31.9 Cr | ₹35.2 Cr | ₹29.2 Cr | ₹-93 Cr |
ROE
11.58%
ROCE
13.86%
Debt/Equity
0.24
Current Ratio
2.13
OPM
-72.49%
NPM
-78.25%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 16 Sept 2025 | Dividend - Rs 0.10 Per Share | DIVIDEND |
| 28 Aug 2024 | Annual General Meeting/Dividend - Re 0.10 Per Share | AGM |
| 09 Oct 2023 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share | STOCK_SPLIT |
| 31 Aug 2023 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 19 Aug 2022 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SIGACHI
View AllNEWS
negative
Business Standard - Markets 1d ago
Sigachi Laboratories reports standalone net loss of Rs 0.55 crore in the March 2026 quarter
Sales rise 54.69% to Rs 0.99 crore
SIGACHIHealthcare